“ASSESSMENT OF SERUM SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) AS A POTENTIAL RISK MARKER IN OBESE WOMEN WITH PREDICTIVE MARKER FOR POLYCYSTIC OVARY SYNDROME”. 2024. CAHIERS MAGELLANES-NS 6 (2): 4972-83. http://cahiersmagellanes.com/index.php/CMN/article/view/782.